Centre for Liver Research and NIHR Liver Biomedical Research Unit, University of Birmingham, , Birmingham, UK.
Postgrad Med J. 2013 Dec;89(1058):685-92. doi: 10.1136/postgradmedj-2012-131640. Epub 2013 Aug 7.
Fibroscan is a quick, non-invasive technique used to measure liver stiffness (kPa), which correlates with fibrosis. To achieve a valid liver stiffness evaluation (LSE) the operator must obtain all the following three criteria: (1) ≥10 successful liver stiffness measurements; (2) IQR/median ratio <0.30 and (3) ≥60% measurement success rate.
To assess the operator training requirements and the importance of adhering to the LSE validity criteria in routine clinical practice.
We retrospectively analysed the LSE validity rates of 2311 Fibroscans performed (1 August 2008 to 31 July 2011) in our tertiary liver outpatients department at the University Hospital Birmingham, UK. The diagnostic accuracy of Fibroscan was assessed in 153 patients, by comparing LSE (valid and invalid) with the modified Ishak fibrosis stage on liver biopsy.
Learning curve analysis highlighted that the greatest improvement in validity of LSE rates occurs in the operator's first 10 Fibroscans, reaching 64.7% validity by the 50th Fibroscan. The correlation between LSE and the fibrosis stage on liver biopsy was superior in patients with a valid LSE (n=97) compared with those with an invalid LSE (n=56) (rs 0.577 vs 0.259; p=0.022). Area under receiving operating characteristics for significant fibrosis was greater when LSE was valid (0.83 vs 0.66; p=0.048). Using an LSE cut-off of 8 kPa, the negative predictive value of valid LSE was superior to invalid LSE for the detection of significant (84% vs 71%) and advanced fibrosis (100% vs 93%).
Fibroscan requires minimal operator training (≥10 observed on patients), and when a valid LSE is obtained, it is an accurate tool for excluding advanced liver fibrosis. To ensure the diagnostic accuracy of Fibroscan it is essential that the recommended LSE validity criteria are adhered to in routine clinical practice.
Fibroscan 是一种快速、非侵入性的技术,用于测量肝硬度(kPa),该值与纤维化相关。为了实现有效的肝硬度评估(LSE),操作者必须满足以下三个标准:(1)至少 10 次成功的肝硬度测量;(2)IQR/中位数比 <0.30;(3)至少 60%的测量成功率。
评估操作者的培训要求和在常规临床实践中遵守 LSE 有效性标准的重要性。
我们回顾性分析了英国伯明翰大学医院三级肝脏门诊在 2008 年 8 月 1 日至 2011 年 7 月 31 日期间进行的 2311 次 Fibroscan 的 LSE 有效性率。通过比较 LSE(有效和无效)与肝活检的改良 Ishak 纤维化分期,评估 Fibroscan 的诊断准确性。
学习曲线分析表明,LSE 有效性率的最大改善发生在操作者的前 10 次 Fibroscan 中,第 50 次 Fibroscan 时达到 64.7%的有效性。在有效 LSE(n=97)患者中,LSE 与肝活检纤维化分期之间的相关性优于无效 LSE(n=56)患者(rs 0.577 比 0.259;p=0.022)。当 LSE 有效时,用于检测显著纤维化的接收者操作特征曲线下面积更大(0.83 比 0.66;p=0.048)。使用 LSE 截断值 8 kPa,有效 LSE 的阴性预测值优于无效 LSE 用于检测显著纤维化(84%比 71%)和进展性纤维化(100%比 93%)。
Fibroscan 需要最少的操作者培训(在患者身上观察到≥10 次),并且当获得有效的 LSE 时,它是一种排除进展性肝纤维化的准确工具。为了确保 Fibroscan 的诊断准确性,在常规临床实践中必须遵守推荐的 LSE 有效性标准。